LifeSci Venture Partners
Venture firm that provides capital and operational support to clinical‑stage healthcare companies. Focuses on companies developing molecular medicine, healthcare delivery, or technology solutions, prioritizing businesses with proof‑of‑concept that plan to transition to public markets within 12–18 months. Portfolio companies access an affiliated global consultancy network of >200 professionals across six verticals for business development, fundraising, and commercialization support.
Industries
Nr. of Employees
small (1-50)
LifeSci Venture Partners
New York, New York, United States, North America
Services
Investment capital provided to clinical‑stage healthcare companies with founder‑aligned terms and patient capital.
On‑demand senior executives and strategic advisory services to support operational needs and execution.
Support for investor story development, outreach strategy and fundraising execution.
Public relations, communications planning and media engagement services.
Global executive recruiting to identify and place senior management and board members.
Advisory services for capital raises, M&A and other financing activities.
Investment capital provided to clinical‑stage healthcare companies with founder‑aligned terms and patient capital.
On‑demand senior executives and strategic advisory services to support operational needs and execution.
Support for investor story development, outreach strategy and fundraising execution.
Public relations, communications planning and media engagement services.
Global executive recruiting to identify and place senior management and board members.
Advisory services for capital raises, M&A and other financing activities.
Expertise Areas
- Clinical‑stage investment
- Venture capital for healthcare
- Business development and commercialization
- Investor relations and fundraising
Key Technologies
- Molecular medicine
- Digital health and healthcare delivery technology
- Clinical development pathway expertise
- Market analytics and partnering tools
News & Updates
Announcement of financing to advance a clinical program.
Series C financing announcement to support multiple Phase 3 trials.
Recognition awarded to a portfolio company.
Announcement of financing to advance a clinical program.
Series C financing announcement to support multiple Phase 3 trials.
Recognition awarded to a portfolio company.